Is atherosclerosis accelerated in young patients with end-stage renal disease? The contribution of paediatric nephrology

Nephrology Dialysis Transplantation

Volumn 17, Issue 5, 2002, Pages 719-722

  Querfeld, Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Children; Renal osteodystrophy; Risk factors

Indexed keywords

ALUMINUM; CALCITRIOL; CALCIUM; PHOSPHATE BINDING AGENT; VITAMIN D;

ADOLESCENT; ADULT; ADULTHOOD; AGED; ARTERY CALCIFICATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOPSY; BRAIN DISEASE; CAUSE OF DEATH; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIALYSIS; HEART ARREST; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERKALEMIA; HYPERPARATHYROIDISM; HYPERTENSION; IATROGENIC DISEASE; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; NEPHROLOGY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RISK FACTOR; SIDE EFFECT; SYMPTOMATOLOGY; UREMIA; WESTERN HEMISPHERE;

EID: 0036095028     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.5.719     Document Type: Article

References (43)

1. Accelerated atherosclerosis in prolonged maintenance hemodialysis
2. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis
3. The role of hypertension in hemodialysis-associated atherosclerosis
4. Dialysis-associated ischemic heart disease: Insights from coronary angiography
5. Controlling the epidemic of cardiovascular disease in chronic renal disease: Report from the National Kidney Foundation Task Force on cardiovascular disease
6. Cardiovascular disease after renal transplantation
7. Chronic renal failure-a vasculopathic state
8. Atherosclerosis in chronic renal failure: A historical perspective
9. Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: A multicentric study in the Ile de France district
10. Genesis of atherosclerosis in uremic patients
11. Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility?
12. Why are lipids not predictive of cardiovascular death in the dialysis patient?
13. Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis
14. Impact of dyslipidaemia in renal transplant recipients
15. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis
16. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity
17. Serum cholesterol in young men and subsequent cardiovascular disease
18. Changes in serum cholesterol level and mortality: A 30-year follow-up. The Finnish cohorts of the seven countries study
19. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis
20. Profile of patients on RRT in Europe and death rates due to major causes of death groups
21. Kidney transplanted children come of age
22. Demography of Dialysis and Transplantation in Children in Europe, 1985
23. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth
24. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults
25. Risk factors for cardiovascular disease in children on maintenance dialysis
26. Coronary artery calcifications in children and young adults treated with renal replacement therapy
27. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis
28. Abnormalities of coronary and carotid arteries in young adults with childhood-onset chronic renal failure
29. Aspects of aluminum toxicity
30. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD
31. Soft tissue calcification in pediatric patients with end-stage renal disease
32. Arterial changes in paediatric haemodialysis patients undergoing renal transplantation
33. Effects of massive doses of ergocalciferol plus cholesterol on pregnant rats and their offspring
34. Warfarin-induced artery calcification is accelerated by growth and vitamin D
35. Regulation of vascular calcification in atherosclerosis
36. Vascular calcification: Expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis
37. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification
38. Phosphate regulation of vascular smooth muscle cell calcification
39. Expression of 1A-hydroxylase in human arterial smooth muscle cells: Identification of an additional cellular site of synthesis and secretion of physiological concentrations of 1,25-dihydroxyvitamin D3
40. Ossification in atherosclerotic carotid arteries
41. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries
42. Active serum vitamin D levels are inversely correlated with coronary calcification